Omega Healthcare Investors Inc.
OHI
$45.79
+0.15%
Omega Healthcare Investors Inc. is a real estate investment trust (REIT) that specializes in investing in healthcare-related real estate properties, primarily skilled nursing facilities, assisted living facilities, and other senior housing assets across the United States, the United Kingdom, and Canada. The company operates as a leading capital partner in the healthcare real estate sector, providing financing to third-party operators while focusing on generating stable rental income for its investors. The current investor narrative centers on the company's recovery and stability following pandemic-era pressures on its operator tenants, with recent attention on its ability to maintain its dividend, manage operator credit quality, and navigate the complex regulatory and reimbursement environment for skilled nursing facilities.…
OHI
Omega Healthcare Investors Inc.
$45.79
Related headlines
Investment Opinion: Should I buy OHI Today?
Rating & Thesis: Hold. OHI is a high-quality, defensive income stock with a strong recovery narrative, but its premium valuation limits near-term upside and introduces compression risk, warranting a neutral stance pending a better entry point or clearer catalyst for multiple expansion.
Supporting Evidence: The stock trades at a forward P/E of 20.95x, which sits near the midpoint of its own wide historical range (9.84x to 44x), suggesting it is fairly valued on this basis. Revenue growth is robust at 15.22% YoY, and profitability is stellar with a net margin of 49.25%. However, the P/S ratio of 10.96x appears elevated for the REIT sector. The dividend yield of 5.94% is attractive and supported by massive TTM FCF of $859.8M. The stock has shown strong relative strength, up 1.06% over 3 months while the SPY fell 4%.
Risks & Conditions: The two biggest risks are valuation compression and operator credit deterioration. This Hold rating would upgrade to a Buy if the forward P/E compressed toward 18x (offering a greater margin of safety) or if revenue growth accelerated further above 20% YoY. It would downgrade to a Sell if TTM FCF meaningfully declined, threatening dividend coverage, or if the technical picture broke down below key support at $43.82. The stock is currently fairly valued relative to its own history but carries a premium on sales and cash flow metrics that demands flawless execution.
Sign up to view all
OHI 12-Month Price Forecast
OHI presents a classic 'wait for a better price' scenario. Its fundamental recovery is impressive and well-supported by cash flow, making a severe bear case unlikely. However, the current valuation already reflects much of this good news, capping the near-term reward. The stance is neutral with medium confidence, as the path of least resistance appears to be range-bound trading. We would upgrade to bullish on a meaningful pullback that improves the valuation (e.g., P/CF below 12x) or on evidence of sustained multiple expansion. A downgrade to bearish would be triggered by a material deterioration in operator credit quality or a breakdown in FCF generation.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Omega Healthcare Investors Inc.'s 12-month outlook, with a consensus price target around $59.53 and implied upside of +30.0% versus the current price.
Average Target
$59.53
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$37 - $60
Analyst target range
Analyst coverage is limited, with only 3 analysts providing estimates, indicating this is a niche REIT with less institutional scrutiny, which can lead to higher volatility and less efficient price discovery. The average revenue estimate for the next period is $1.14 billion, with a range from $1.10 billion to $1.22 billion, reflecting a degree of uncertainty; the lack of explicit price targets and a consensus recommendation in the provided data further underscores the sparse coverage, requiring investors to rely more heavily on independent fundamental and technical analysis.
Bulls vs Bears: OHI Investment Factors
The evidence for OHI presents a nuanced picture where bullish fundamentals are counterbalanced by bearish valuation and sentiment indicators. The bull side currently has stronger evidence, anchored in demonstrable financial recovery (15.22% YoY revenue growth), exceptional profitability (49.25% net margin), and fortress-like cash flow. The most critical tension in the investment debate is whether the company's premium valuation multiples (P/S 10.96x, P/CF 14.94x) are justified by its recovery trajectory and defensive income profile, or if they represent over-optimism that leaves the stock vulnerable to multiple compression.
Bullish
- Strong Revenue Recovery Trajectory: Q4 2025 revenue of $321.8 million grew 15.22% YoY, and sequential quarterly growth from $276.8M to $321.8M throughout 2025 demonstrates a clear recovery path. This growth is driven by the stabilization of its skilled nursing facility operators post-pandemic.
- Exceptional Profitability & Cash Flow: The company boasts a Q4 net margin of 49.25% and generated $859.8M in TTM free cash flow. This robust cash generation provides ample coverage for its 5.94% dividend yield and supports financial flexibility for acquisitions or debt reduction.
- Solid Balance Sheet & Low Volatility: A conservative debt-to-equity ratio of 0.82 and a strong current ratio of 3.46 indicate a healthy financial position. The stock's beta of 0.58 suggests it is 42% less volatile than the market, offering defensive characteristics.
- Attractive Dividend Yield: The current dividend yield of 5.94% is a key income driver for investors. It is supported by strong FCF, making it a central component of the total return thesis for this REIT.
Bearish
- Elevated Valuation Multiples: With a P/S of 10.96x and a P/CF of 14.94x, the stock trades at a premium typical for growth stocks, not income-focused REITs. The forward P/E of 20.95x, while a discount to the trailing 22.25x, still implies high earnings expectations.
- High Short Interest & Limited Coverage: A short ratio of 7.26 indicates significant bearish sentiment and potential for volatility. Furthermore, coverage by only 3 analysts suggests less institutional scrutiny and potentially less efficient price discovery.
- Recent Momentum Divergence: The stock is down 5.18% over the past month, diverging from its strong yearly trend and signaling potential consolidation or profit-taking. This pullback occurred as the price approached its 52-week high resistance.
- Sector-Specific Operator Risk: As a healthcare facility REIT, OHI's financial health is tied to its operator tenants' ability to navigate staffing shortages, regulatory changes, and reimbursement pressures. Any operator distress could directly impact rental income.
OHI Technical Analysis
The stock is in a sustained uptrend, having gained 18.80% over the past year, and is currently trading near the upper end of its 52-week range, approximately 89% of the way from its 52-week low of $35.04 to its high of $49.14, indicating strong momentum but also potential overextension. Recent momentum shows a divergence, with the stock down 5.18% over the past month, which contrasts with the positive 1-year trend, suggesting a potential consolidation or profit-taking phase after a strong run; however, the 3-month return remains positive at 1.06%. Key technical support is anchored at the 52-week low of $35.04, while immediate resistance is at the 52-week high of $49.14; a decisive breakout above $49.14 would signal a continuation of the bullish trend, while a breakdown below recent lows near $43.82 could indicate a deeper correction, though the stock's low beta of 0.58 suggests it is 42% less volatile than the broader market, which may cushion downside moves.
Beta
0.58
0.58x market volatility
Max Drawdown
-9.5%
Largest decline past year
52-Week Range
$35-$49
Price range past year
Annual Return
+21.6%
Cumulative gain past year
| Period | OHI Return | S&P 500 |
|---|---|---|
| 1m | -4.4% | +0.5% |
| 3m | +3.4% | -2.1% |
| 6m | +15.0% | +4.0% |
| 1y | +21.6% | +29.5% |
| ytd | +2.8% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OHI Fundamental Analysis
Revenue growth is robust, with Q4 2025 revenue of $321.8 million representing a 15.22% year-over-year increase, and the sequential trend from Q1 to Q4 2025 shows consistent quarterly revenue growth from $276.8 million to $321.8 million, indicating a strong recovery trajectory. The company is highly profitable, with Q4 2025 net income of $164.7 million and a net margin of 49.25%, and while the gross margin of 47.22% for the quarter is healthy, it has fluctuated quarterly, reflecting the variable cost structure of its triple-net lease model. The balance sheet is solid with a conservative debt-to-equity ratio of 0.82 and a strong current ratio of 3.46, and the company generates substantial cash flow, with trailing twelve-month free cash flow of $859.8 million, providing ample coverage for its dividend and supporting financial flexibility.
Quarterly Revenue
$321817000.0B
2025-12
Revenue YoY Growth
+0.15%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$859844000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OHI Overvalued?
Given the positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 22.25x, while the forward P/E is 20.95x; the slight discount on the forward multiple suggests the market expects modest earnings growth. Compared to sector averages (data not available for direct comparison), the stock's valuation must be assessed contextually; its P/S ratio of 10.96x and P/CF ratio of 14.94x appear elevated for a REIT, potentially reflecting a premium for its healthcare sector focus and dividend yield. Historically, the stock's own trailing P/E has ranged significantly, from lows near 9.84x in early 2022 to highs above 44x in early 2023; the current P/E of 22.25x sits near the midpoint of this historical range, suggesting the stock is neither excessively cheap nor expensive based on its own history.
PE
22.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 10x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is not leverage—the debt-to-equity ratio of 0.82 is manageable—but rather the sustainability of its exceptional margins and cash flow. The net margin of 49.25% is extraordinarily high for a REIT and may face pressure if operator costs rise or reimbursement rates falter. Furthermore, the business model carries inherent operator credit risk; tenant distress in the volatile skilled nursing sector could lead to rent deferrals or property re-leasing costs, directly impacting the $859.8M in annual FCF that supports the dividend.
Market & Competitive Risks: The stock faces significant valuation compression risk, trading at a P/S of 10.96x and a P/CF of 14.94x, which are premiums more aligned with growth stocks than typical REITs. A shift in market sentiment away from 'bond-proxy' or defensive income stocks could trigger a derating. Competitive risks include other healthcare REITs and private capital vying for attractive assets, potentially capping growth. The low beta of 0.58 offers some insulation from broad market swings, but sector-specific negative news, like the recent article questioning peer Medical Properties Trust, can create sentiment-driven sell-offs.
Worst-Case Scenario: A severe downturn would involve a simultaneous failure: a major operator bankruptcy triggering a wave of rent defaults, combined with a sharp rise in interest rates that increases financing costs and compresses REIT valuations across the board. This could force a dividend cut despite strong historical FCF, shattering the income investor thesis. Quantifying the downside, a retest of the 52-week low of $35.04 from the current price near $45 represents a potential loss of approximately -22%. A more severe bear case, factoring in multiple compression and earnings disappointment, could see a decline of 30-35%.
FAQ
The key risks are: 1) Valuation & Sentiment Risk: High short interest (short ratio 7.26) and premium multiples make the stock vulnerable to negative news or a broader derating of REITs. 2) Operator Credit Risk: OHI's income depends on third-party healthcare operators; any significant tenant bankruptcy could lead to rent defaults and property vacancies. 3) Regulatory/Reimbursement Risk: Changes in government healthcare funding (Medicaid/Medicare) directly impact operator profitability and their ability to pay rent. 4) Dividend Sustainability Risk: While covered by FCF now, a payout ratio of 132% of earnings highlights sensitivity to any earnings decline. Operator credit risk is likely the most severe, as it directly threatens the core revenue stream.
Our 12-month forecast outlines three scenarios. The Base Case (60% probability) sees the stock trading in a range of $44 to $48, as steady execution meets valuation headwinds. The Bull Case (25% probability) projects a breakout above the 52-week high to $49-$53, driven by earnings beats and multiple expansion. The Bear Case (15% probability) warns of a drop to $35-$40 on operator distress or macro headwinds. The base case is most likely, predicated on the assumption that the company's strong fundamental recovery (15.22% revenue growth) will continue but that its premium valuation will limit dramatic upside in the absence of a new catalyst.
OHI is fairly valued relative to its own earnings history but carries a premium on other metrics. Its forward P/E of 20.95x sits near the midpoint of its wide historical P/E range, suggesting a fair price for its earnings. However, its Price-to-Sales ratio of 10.96x and Price-to-Cash-Flow ratio of 14.94x are elevated, typical of growth stocks rather than REITs, indicating the market is paying up for its recovery trajectory and defensive income. Compared to sector peers, these multiples suggest a premium valuation. The market is pricing in continued execution on its growth path and stable, high cash flow generation.
OHI is a good buy for income-oriented investors with a medium-term horizon who can tolerate sector-specific risks, but it is not an obvious bargain today. The 5.94% dividend yield is attractive and well-covered by substantial free cash flow. However, with the stock trading at premium valuation multiples (P/S 10.96x) and near its 52-week high, the near-term upside may be limited. It becomes a more compelling buy on a pullback to the low-$40s, which would offer a higher yield and better valuation. The biggest downside risk is operator distress, which could pressure the stock toward its 52-week low of $35.04.
OHI is primarily suitable for long-term, income-focused investors. Its low beta (0.58) and high dividend yield (5.94%) are hallmarks of a defensive, buy-and-hold stock for a portfolio's income sleeve. The recovery narrative and growth in cash flow also support a multi-year holding period to realize the full benefit of the business stabilization. It is less suitable for short-term trading due to its lower volatility and the potential for range-bound action as it digests its recent gains. A minimum suggested holding period is 2-3 years to collect several dividend payments and allow the fundamental story to unfold.